ValenciaLeaks ransomware group lists globe.com.bd on its leak site

• Ransomware group: ValenciaLeaks
• Country: Bangladesh
• Sector: Professional Services
• Announcement date: September 18, 2024

ValenciaLeaks claims data breach at Globe Pharmaceuticals Ltd.

The threat actor known as ValenciaLeaks has listed Globe Pharmaceuticals Ltd. on its leak site. According to the announcement made on September 18, 2024, the group claims that the organization's data has been compromised. This development follows a pattern often seen in modern cyberattacks where threat actors use public leak sites to pressure victims through exposure.

Ransomware groups frequently employ a tactic known as double extortion. In these scenarios, attackers do not merely encrypt an organization's systems to disrupt operations; they also exfiltrate sensitive information before the encryption occurs. By threatening to release this stolen data on public forums or specialized leak sites, the attackers aim to maximize their leverage during ransom negotiations, targeting the victim's reputation and regulatory standing.

Details of the alleged claim

The announcement by ValenciaLeaks alleges that the organization's data has been compromised. While the listing confirms the target, specific details regarding the nature of the exfiltrated data have not been provided by the group. The only information available regarding the scope of the breach is the size of the dataset mentioned in the claim.

Data characteristics

The listing provides limited information regarding the content of the alleged theft:

• The claimed dataset size is 200 MB.

No specific details regarding the nature of the exfiltrated data have been provided, and no specific file counts or ransom demands have been disclosed by the threat actor.

About Globe.com.bd

Globe.com.bd is a professional services and business solutions provider based in Bangladesh. The company offers consulting and operational support services across various sectors. Based on the details provided, the organization serves as a provider of business solutions, and the entity specifically identified in the leak site announcement is Globe Pharmaceuticals Ltd.

Risk assessment and industry implications

Until the content of the alleged data is clarified, the risks to the organization's operational processes and corporate reputation remain uncertain. The 200 MB size of the alleged dataset suggests that a limited but potentially sensitive set of corporate or commercial information may have been exposed. Because the organization operates in the pharmaceutical sector, the leakage of intellectual property or trade secrets could potentially lead to a loss of competitive advantage.

Furthermore, such leaks may create secondary risks, such as the use of employee data or corporate correspondence in targeted phishing attacks. When sensitive internal communications or personnel details are leaked, attackers can craft highly convincing social engineering campaigns to target employees or business partners, further compromising the network.

In the pharmaceutical and professional services sectors, maintaining the integrity of proprietary research and client data is paramount. Organizations in these sectors typically focus on robust defensive measures to mitigate such risks. Common defensive steps include implementing strict access controls, maintaining comprehensive logging to detect unauthorized data movement, and ensuring regular, offline backups are available. Additionally, continuous monitoring for unusual outbound traffic can help identify exfiltration attempts before significant amounts of data are moved out of the network.